Written question asked by Chi Onwurah (Labour) on Thursday, 24 March 2022, in the House of Commons. It was due for an answer on Monday, 28 March 2022. It was answered by Edward Argar (Conservative) on Thursday, 31 March 2022 on behalf of the Department of Health and Social Care.

Medical Technologies Directorate: Life Sciences

Question: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 December 2021 to Question 92932, and with reference to page 10 of the Life Sciences Vision, what assessment his Department has made of how the Medical Technologies Directorate can contribute to positioning the NHS as an Innovation Partner.

Answer: The Medical Technologies Directorate is developing its strategy to be published in summer 2022, which will support the Life Sciences Vision. The Directorate has undertaken engagement with industry partners to identify the key priorities for the MedTech Strategy. This will include supporting an innovative and dynamic MedTech market to ensure that new products reach the National Health Service quickly through streamlined pathways. The forthcoming strategy will provide further details on this priority.

Secondary information

Type: Written question
Reference: 146620
Session: 2021-22
Related items: Medical Technologies Directorate: Life Sciences
Monday, 20 December 2021
Written questions
House of Commons
Subjects: Life sciences Medical Technologies Directorate
Link: View this Written question on www.parliament.uk